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Abstract
Background: Complementary and alternative medicine (CAM) is common in patients with chronic disease such as
diabetes mellitus. The primary objective of the study was to determine the overall prevalence and type of CAM use
in individuals with diabetes mellitus (DM) in Western Sydney and to compare the prevalence and factors
associated with CAM use with the literature.
Methods: A multicenter cross-sectional study was undertaken using a self-completed questionnaire distributed to
patients with DM attending a public hospital and specialist endocrinology clinics in the region. The type of DM
and pattern of CAM utilisation were analyzed.
Results: Sixty nine people responded to the questionnaire: age range of 18-75 years during a twelve week
collection period. Overall, 32 respondents with diabetes were using some form of CAM, resulting in a utilisation
rate of 46.3%. Twenty of the 32 CAM users used CAM specifically to treat their diabetes accounting for 28.9% of
the respondent sample population. Multivitamins (40%), cinnamon, Co-enzyme q10 and prayer were the most
frequently used CAM modalities. There was no significant difference between males and females, age range,
income or diabetes complications between CAM and non-CAM users. (p values each > 0.05) The factor most
significantly associated with CAM usage was being born overseas (p = 0.044).
Conclusions: Almost half the respondents (46.3%) used CAM: 28% used CAM specifically to treat their diabetes.
Individuals born overseas were significantly more likely to use CAM than those born in Australia. Other factors such
as age, gender, wealth and duration of living with diabetes were not associated with higher rate of CAM usage.
Background
Diabetes Mellitus (DM) is recognized as a major inter-
national health problem leading to significant morbidity
and mortality and is the fastest growing chronic disease
in Australia. In fact, DM has been identified as Austra-
lia’s fifth national health priority since 1996.
The baseline 1999/2000 AusDiab study showed 7.5%
of the Australian population aged 25years and older had
diabetes, including 8.0% of males and 7.0% of females
[1]. In people 75yrs and over 23.6% had diabetes, most
had type 2 diabetes(T2DM) but the estimates include
type 1(T1DM).
Complementary and alternative medicine (CAM) is
defined as a group of diverse medical and health prac-
tices that are not presently considered to be part of con-
ventional medicine.
The conventional pharmacological treatment of Type
1d i a b e t e s( T 1 D M )i si n s u l i n . The different therapies
available for Type 2 diabetes (T2DM) include lifestyle
modification of diet and exercise, oral medications and
insulin. One of the most commonly used conventional
medicines for T2DM is metformin, which was originally
derived from Galega officinalis (French lilac or goat’s
rue), once considered a complementary medicine
(CAM) used to treat diabetes [2].
Approximately half the Australian population uses CAM
and spent an estimated $2.3 billion on CAM in 2000,
which is nearly four times the public contribution to all
pharmaceuticals [3]. The utilization of complementary
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any medium, provided the original work is properly cited.health practitioners has also increased in recent times. An
Australian National Health Survey in 2004-05 showed that
3.8% of the population (~748,000 people) had seen one of
seven selected complementary health practitioners com-
pared to 2.8% of the population in 1995. The most com-
monly consulted therapists were chiropractors,
naturopaths and acupuncturists [4]. The actual prevalence
of Australian CAM usage can be based on South Austra-
lian data where CAM use is reported to range between 48
and 53% [5].
Whilst there is little published literature on the preva-
lence of CAM usage in the Western Sydney region, a
1996 study reported 52% of 325 people and their carers
attending an inner metropolitan Sydney teaching hospi-
tal Emergency Room used CAM, which is consistent
with existing Australian and overseas data [6].
When considering the use of CAM amongst people liv-
ing with diabetes, a North American study has shown the
prevalence to be between 31% and 57% [7]. The current
literature suggests female gender, greater wealth, higher
educational status and having a chronic disease are all
factors significantly associated with CAM use [8]. In
addition, diabetes is an independent predictor of CAM
use in the general population [9]. Most people with dia-
betes use conventional medicines and there are risks of
interactions and adverse effect as well as unknown bene-
fits associated with concurrent CAM- usage.
The primary aim of the research was to identify the
prevalence and type of CAM usage by people with dia-
betes in Western Sydney. The secondary aim was to
identify the demographic, socioeconomic and disease-
specific features associated with CAM use and compare
these factors to current literature.
Methods
A cross sectional survey was distributed over twelve
weeks between June and August 2008. A two stage sam-
pling design was conducted which consisted of a pilot
test followed by a cross-sectional multicenter study using
self-completed anonymous questionnaires. The question-
naire was designed by the researchers following a litera-
ture review to identify the type of CAM previously used
by people living with diabet e s .T h eS y d n e yW e s tA r e a
Health Service (SWAHS) Scientific Advisory and the
Human Research Ethics Committee (HREC), Nepean
Campus approved the project (HREC Reference Number:
08/027/08/NEPEAN/42).
The pilot test involved the researcher distributing the
questionnaire to five people with diabetes at a tertiary
teaching hospital to establish face validity and identify
any questions that needed to be altered prior to using
the questionnaire in the main study. The pilot test was
important to ensure the target audience understood the
questions; the wording was appropriate and would yield
the required data. Content validity was established by
one researcher with expertise in CAM use and question-
naire design through a comprehensive literature review
of similar studies and surveys. The pilot study was suc-
cessful and no questions were modified prior to the
main study.
The questionnaire comprised of 32 questions using a
combination of open and closed question response for-
mats [See Additional File 1]. Questions were divided into
three domains related to demographic data, diabetes-
related information and CAM usage. Socioeconomic infor-
mation sought included gender, age group, educational,
marital and employment status and country of birth.
Diabetes-specific information included type and duration
of diabetes, frequency of blood glucose monitoring, last
glycosylated haemoglobin A1c level, and presence of any
diabetes complications. CAM-related information
included type of CAM used and the reason for use.
Following a literature review, the researchers grouped
the CAM into three broad categories to account for the
potential variety of therapies used, which included: vita-
mins and minerals, herbal medicines and relaxation and
other therapies. Information was collected about the fol-
lowing CAM therapies:
Vitamins/minerals: chromium, vitamin E, Co-enzyme
Q10, L-carnitine, selenium, vitamin C, Vanadium, and
magnesium.
Herbal products: ginseng (Panax quinquefolium), gar-
lic (Allium sativum), onion (Allium cepa), ivy gourd
(Coccinia grandis), holy basil (Ocimum tenuiflorum),
cinnamon (Cinnamomum verrum), fenugreek (Trigonella
foenum-graecum), milk thistle (Silybum mariunum), bit-
ter melon (Momordica charantia) and Gymnena
sylvestre.
Relaxation and other therapies: acupuncture, tai chi,
massage, yoga, prayer, essential oils, and reflexology.
Although botanical names are cited here, the common
names were used in the questionnaire because most
respondents were more likely to recognise them.
The inclusion criteria included
￿ Those aged 18 yrs and over
￿ Known T1DM or T2DM and able to give informed
consent to participate.
The exclusion criteria included
￿ Inability to communicate in spoken or written
English
￿ Age under 18
￿ Those having participated in the pilot test.
￿ Those with intellectual disability or active psychia-
tric disease that prevented them from giving
informed consent.
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distributing the questionnaire to individuals with dia-
betes in two separate private endocrine clinics in Parra-
matta and public outpatient clinics and medical wards
of the Nepean Hospital in Western Sydney over a 12
week period. These centers were selected because the
researcher was able to access the relevant clinics to
recruit participants.
The researchers estimated that there were approxi-
mately 8 patients per week in both of the endocrine
clinics and overall 24 patients from the public outpatient
clinics and wards of Nepean hospital during the 12 week
collection period, thus a total estimated sampling popu-
lation of 120 individuals in Western Sydney. From this
estimated sample, there were a total of 69 respondents.
In each setting, the treating endocrinologist or clinic
health staff asked people with DM consecutively
whether they would be willing to complete the anon-
ymous questionnaire. A participant information state-
ment that explained the aims of the project and
indicated that the return of the questionnaire would be
regarded as consent to use the anonymous information
for the research purposes outlined was attached to each
questionnaire.
Data analysis
Qualitative and quantitative data analysis processes were
used to analyse the data. The data analysis was con-
ducted using Statistical Package for the Social Sciences
(SPSS; SPSS Inc, Chicago, IL) software 9 version 12) for
Windows. Results for CAM and non-CAM users were
recorded as mean ± standard error and, where appropri-
ate, analysed using standard non-parametric methods
including Chi-squared test and Fisher Exact analysis. A
p value of 0.05 was used to determine any statistically
significant differences between CAM and non-CAM
users. The qualitative content analysis of open-ended
questions was undertaken using the framework method
[10]. The framework method consists of a five-step pro-
cess that involves becoming familiar with the data, iden-
tifying a thematic framework, indexing and charting key
themes and mapping and interpreting the findings.
Results
Overall, 69 questionnaires were completed during the
twelve week collection period from an estimated sample
population of 120. Of the 69 respondents, 32 used CAM
for general health and 20 of these used CAM specifically
to treat their diabetes. Table 1 shows the proportions of
CAM usage based on demographic and diabetes specific
related data.
Thirty two respondents (46.3%) used one or more
CAM therapies either for diabetes or general health pur-
poses. Of these, 12 (37.5%) used CAM for both general
health and diabetes and 20 (62.5%) used CAM specifi-
cally for their treatment of diabetes.
Pearson Chi square was used to determine associa-
tions among demographic and diabetes specific data in
relation to CAM use. Some of the demographic factors
of interest included gender, weekly income, educational
status, country of birth, working and marital status. Sig-
nificantly, overseas born individuals with diabetes were
more likely to use CAM, 15/24 (63%) compared with
17/45 (38%) Australian born respondents (p = 0.044).
The questionnaire asked respondents to list their
macro vascular or micro vascular complications. In
total, 17 of the 31 (55%) patients who used CAM for
any purpose had one or more diabetes complications
but there was no significant association between the
presence of diabetic complications and the rate of CAM
use. There was no statistically significant data between
the type of diabetes, duration or most recent HbA1C
and the use of CAM.
Of the 20 respondents who used CAM specifically for
the treatment of diabetes, the most common types used
Table 1 Proportion of CAM use related to demographic
and diabetic related data and the statistical significance
of these factors
Demographic Factors
Category Using CAM No CAM Use P Value
Male 17/35 (49%) 18/35 (51%)
Female 15/34 (43%) 19/34 (57%) 0.867
Australian born 17/45(38%) 28/45 (62%)
Overseas born 15/24(63%) 9/24 (37%) 0.044*
Working 15/29(52%) 14/29(48%)
Not Working 17/40 (43%) 23/40(57%) 0.419
Income < $1000/wk 21/44 (47%) 23/44(53%)
Income > 1000/wk 11/20 (55%) 9/20 (45%) 0.948
Tertiary Qualifications 11/20 (55%) 9/20 (45%)
Other Qualifications 21/44(48%) 24/44 (52%) 0.633
Married 15/35(43%) 20/35(57%)
Not Married 17/33(51%) 16/33(49%) 0.832
Diabetes-specific Data
Category Using CAM No CAM Use P Value
Type 2 DM 24/50(48%) 26/50(52%) 0.704
Type 1 DM 5/14(36%) 9/14 (64%)
> 10 yrs Duration 14/30 (47%) 16/30 (53%) 0.603
< 10 yrs duration 17/32 (53%) 15/32 (47%)
Complications 17/31 (55%) 14/31 (45%) 0.325
No Complications 14/33 (42%) 19/33(58%)
Oral Meds/insulin 30/64(47%) 34/64(53%) 0.408
Diet/exercise only 1/4 (25%) 3/4 (75%)
HbA1C < 10 23/45(51%) 22/45 (49%) 0.180
HbA1c > 10 9/21(43%) 12/21(57%)
*Statistical Significance of Difference P ≤ 0.05
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(25%) and coenzyme q10(25%)
The final question asked respondents to indicate
whether or not they would be willing to use CAM in
the future, regardless of their current CAM usage. Sixty
one responded. Of these, 41 (67%) stated they would be
willing to use CAM, nine indicated they would not use
CAM and 11 were unsure.
The different types of CAM used to manage diabetes
are shown in table 2. Whilst the majority of respondents
used CAM for diabetes, only one respondent suggested
he or she used CAM to control their blood glucose levels.
Discussion
The overall prevalence of CAM use in Western Sydney
(46%) was similar to previously published prevalence
data in South Australia (~48-53%) and inner metropoli-
tan Sydney (~52%). In comparison to overseas literature,
the prevalence of CAM use in people with diabetes in
Western Sydney was consistent with the UK (46%) [11]
and lower than similar studies in the USA (73%) [7],
India (68%) [12], Mexico (62%) [13] but higher than in
Saudi Arabia (30%)[14].
The majority of patients in the study were selected
either in hospital or private endocrine clinics. It is possi-
ble that they had a longer duration of disease, poorer
control or higher rates of complications leading to hos-
pitalization. Thus, some of these factors may have
influenced the overall prevalence of CAM use and need
to be considered when compared to the general Austra-
lian diabetic population.
T h ea v a i l a b i l i t yo fC A Mi nt h eW e s t e r nW o r l d( U S A ,
UK) is similar to Australia. It is predominantly privately
funded and freely available from pharmacies or health
food stores. However, there may be differences in types
of CAM available and cultural acceptance between Aus-
tralia and countries like India or Mexico which may
explain the lower prevalence rate in our study.
In contrast to the literature, this study did not show
any association between CAM usage and females who
are wealthy and highly educated. The main reason these
factors were not proven significant was due to small
sample size which may not be representative of larger
population based studies. In addition, there are a higher
proportion of people from lower socioeconomic status
and levels of educational attainment that live in Western
Sydney.
There were no statistically significant relationships
between CAM usage and duration of diabetes, type of
treatment and glycosylated HbA1c levels. We cannot
assume that the presence of complications leads to
higher rates of CAM usage. There is scope for prospec-
tive studies of CAM use amongst people newly diag-
nosed with diabetes and throughout the progression of
their disease. This would assist in delineating whether
the development of complications leads to higher rates
of CAM usage. Our study did not investigate whether
the presence of other co-morbid chronic illness affects
the rate of CAM usage. Thereby, it was not possible to
know whether the presence of diabetes alone was an
independent predictor of CAM usage.
This study has shown that being born overseas is
associated with a higher rate of CAM usage. This could
be due to experience, upbringing, and belief system or
in acceptance of CAM therapies. Approximately one
third of the Western Sydney population were born over-
seas and migrated to Australia, significantly more than
other regions. Thus, it may be difficult to extrapolate
this data to the general Australian diabetic population.
This association also warrants further investigation in
Australia and in other countries.
The majority of respondents (67%) indicated they
would be willing to use CAM for diabetes in the future
if they had positive information about the benefits from
their health care providers. This would suggest that
individuals living with diabetes feel CAM may be a safe
option and open to compliance with these therapies.
The most common types of CAM used were multivita-
mins, cinnamon, prayer and coenzyme q10. Of these treat-
ments, cinnamon has had conflicting data on efficacy in
the reduction of serum glucose levels. It is apparent that
s o m eo ft h es u r v e yr e s p o n d e n t sa r ea w a r eo fap o t e n t i a l
Table 2 Types of CAM therapies used specifically to treat
diabetes
Type of CAM used for DM Number of CAM users
(n = 20)
Multivitamin 8/20
Cinnamon 5/20
Co-enzyme Q10 5/20
Prayer 5/20
Garlic 4/20
Magnesium 3/20
Vitamin E 3/20
Massage 2/20
Fish oil/Omega 3 2/20
Yoga 2/20
Vitamin D 2/20
Gymnena slyveste 1/20
Vitamin B 1/20
Iron 1/20
Fenugreek 1/20
American Ginseng 1/20
Relaxation therapy 1/20
Jerusalem Artichokes(Helianthus
tuberosus)
1/20
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ment for their diabetes. However, further clinical trials
into the effect of cinnamon in addition to the use of con-
ventional pharmacological treatment are warranted
[15,16].
The study showed that prayer remains a common form
of CAM used by those with diabetes which is consistent
with a previous study [17]. This suggests that individuals
with chronic disease often believe in spiritual practices
that aid in their personal healing process.
Whilst the study indicated significant use of multivita-
mins and co-enzyme q10, single herbal remedies such as
Gymnena slyveste, American ginseng and Jerusalem
Artichokes (Helianthus tuberosus) was low. One respon-
dent commented that Jerusalem artichoke reduced his
or her blood glucose levels although specific details
were not given.
The major limitation of the study was its small sample
size. Some of the respondents choose not to answer cer-
tain questions related to income, marital status and ter-
tiary qualifications. The sampling population of 120 was
an estimate based on the number of patients who attended
the two endocrine outpatient clinics and Nepean Hospital
and were available to complete the questionnaire during
the twelve week collection period. The exact rate of refusal
to complete the questionnaire was not recorded; therefore,
an exact response rate could not be calculated.
Conclusion
Respondents with diabetes who participated in the study
frequently use CAM to treat their diabetes and for gen-
eral health. It appears that the majority of patients with
DM who use CAM do so for the treatment of their dia-
betes. Health care professionals should be aware that
people with diabetes use CAM and take a thorough his-
tory to document any such therapies and monitor out-
comes to note benefits or potential side effects.
Additional material
Additional file 1: Questionnaire on the Use of Complementary and
Alternative Medicine among People living with Diabetes in Sydney.
The distributed questionnaire collecting demographic, diabetes specific
and CAM related data.
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